[TCTAP Workshops] Management of Ischemic Heart Disease 2025: ISCHEMIA Trial Has Been a Major Inescapable Turning Point

April 24, 2025 / 8:10 AM ~ 9:40 AM 📌 Coronary Theater, Level 1

  • May 09, 2025
  • 105
Moderator(s): Seung-Jung Park, Gregg W. Stone
Panelist(s): Youngkeun Ahn, Wai Sun Choo, Myeong-Ki Hong, Fahim Haider Jafary, Ho Lam, Mamas Mamas, Yoshinobu Murasato, Imad Sheiban, Alan C. Yeung

  • Left Main and Multi-Vessel Disease Revascularization: Updated Guideline and Beyond 2025
    Sripal Bangalore
  • A Novel Ongoing Trial of PCI vs. CABG: RECHARGE
    Gregg W. Stone
  • DM and Three-Vessel Disease: Why We Need New RCTS- DEFINE-DM Trial
    Duk-Woo Park
  • Future Role of Intracoronary Physiology: Beyond FAME Series
    Nico Pijls
  • Unmet Need for FFR in Left Main PCI: FATE-MAIN Trial
    Jung-Min Ahn
  • Master's Key Case and Review: Multi-Vessel PCI in Acute Coronary Syndromes: Decision-Making With FFR or Intracoronary Imaging
    Shamir R. Mehta
  • Panel Discussion I

Master's Opinion - Debate: OMT vs. Surgery for Multi-Vessel Disease in CCS

  • OMT First
    Sripal Bangalore
  • Surgery Is Still Standard
    David Paul Taggart
  • Panel Discussion II
Share this Post:
Video List